DGAP-News

Abivax publishes Universal Registration Document 2021 'Document d'Enregistrement Universel' - Seite 2

Contacts

Abivax Finance Didier Blondel [e-mail] [phone]	Abivax Communications Regina Jehle [e-mail] [phone]	Investors LifeSci Advisors Chris Maggos [e-mail] [phone]
Public Relations & Investors Europe MC Services AG Anne Hennecke [e-mail] [phone]	Public Relations France Actifin Ghislaine Gasparetto [e-mail] [phone]	Public Relations USA Rooney Partners LLC Marion Janic [e-mail] [phone]

 

DISCLAIMER

This press release contains forward-looking statements, forecasts and estimates (including patient recruitment) with respect to certain of the Company's programs. Although the Company believes that its forward-looking statements, forecasts and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors that have been deemed reasonable, such forward-looking statements, forecasts and estimates are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated in such forward-looking statements, forecasts and estimates. A description of these risks, contingencies and uncertainties can be found in the documents filed by the Company with the French Autorité des Marchés Financiers pursuant to its legal obligations including its registration document (Document d'Enregistrement Universel). Furthermore, these forward-looking statements, forecasts and estimates are only as of the date of this press release. Readers are cautioned not to place undue reliance on these forward-looking statements. Abivax disclaims any obligation to update these forward-looking statements, forecasts or estimates to reflect any subsequent changes that the Company becomes aware of, except as required by law.